Hub Services Special Report 2016: Connectivity with patients drives pharma growth
Market forces are driving pharma manufacturers and patients closer together – and now the pharma industry has a pathway with which to do this. The relationships are growing while pharma contends with regulatory constraints and the competing desires of other parts of the healthcare ecosystem – notably, physicians and pharmacies – to retain patient loyalty. For many, the pathway is being established through hub providers, organizations that are often independent third parties, and which provide access to financial support for high-cost specialty products, counseling and support for the patient journey, and highly valued data on outcomes and results valued by payers.
Lash Group’s Loreen Brown, Senior Vice President of Product Strategy & Commercialization Excellence, provides input on Hub services in this special report.